×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LTRN – lantern pharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LTRN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/14
08:53 am
ltrn
Lantern Pharma Launches withZeta.ai — the World's First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development — Subscriptions Now Open; Debut Events at Nasdaq MarketSite on 4/16 and at AACR 2026 from 4/17 to 4/22 [Yahoo! Finance]
Low
Report
Lantern Pharma Launches withZeta.ai — the World's First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development — Subscriptions Now Open; Debut Events at Nasdaq MarketSite on 4/16 and at AACR 2026 from 4/17 to 4/22 [Yahoo! Finance]
4/14
08:31 am
ltrn
Lantern Pharma Launches withZeta.ai — the World’s First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development — Subscriptions Now Open; Debut Events at Nasdaq MarketSite on 4/16 and at AACR 2026 from 4/17 to 4/22
Low
Report
Lantern Pharma Launches withZeta.ai — the World’s First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development — Subscriptions Now Open; Debut Events at Nasdaq MarketSite on 4/16 and at AACR 2026 from 4/17 to 4/22
4/9
01:07 pm
ltrn
Lantern Pharma Inc. (LTRN) Shareholder/Analyst Call Transcript [Seeking Alpha]
Low
Report
Lantern Pharma Inc. (LTRN) Shareholder/Analyst Call Transcript [Seeking Alpha]
4/2
09:08 pm
ltrn
Lantern Pharma Inc (LTRN) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... [Yahoo! Finance]
Medium
Report
Lantern Pharma Inc (LTRN) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... [Yahoo! Finance]
4/2
08:10 am
ltrn
Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the World's First Multi-Agentic Co-Scientist for Rare Cancers — 8:30 AM Eastern, April 9, 2026
High
Report
Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the World's First Multi-Agentic Co-Scientist for Rare Cancers — 8:30 AM Eastern, April 9, 2026
3/30
07:57 pm
ltrn
Lantern Pharma outlines $15B–$20B market potential as AI-driven pipeline advances and funding needs intensify [Seeking Alpha]
High
Report
Lantern Pharma outlines $15B–$20B market potential as AI-driven pipeline advances and funding needs intensify [Seeking Alpha]
3/30
07:57 pm
ltrn
Lantern Pharma Inc. (LTRN) Q4 2025 Earnings Call Prepared Remarks Transcript [Seeking Alpha]
High
Report
Lantern Pharma Inc. (LTRN) Q4 2025 Earnings Call Prepared Remarks Transcript [Seeking Alpha]
3/30
04:05 pm
ltrn
Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
High
Report
Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
03:48 pm
ltrn
Form SCHEDULE 13D/A Lantern Pharma Inc. Filed by: Bios Equity Partners, LP
Medium
Report
Form SCHEDULE 13D/A Lantern Pharma Inc. Filed by: Bios Equity Partners, LP
4/10
08:00 am
ltrn
Form 8-K Lantern Pharma Inc. For: Apr 09
Medium
Report
Form 8-K Lantern Pharma Inc. For: Apr 09
4/3
10:53 am
ltrn
Form SCHEDULE 13G Lantern Pharma Inc. Filed by: SATTERFIELD THOMAS A JR
Medium
Report
Form SCHEDULE 13G Lantern Pharma Inc. Filed by: SATTERFIELD THOMAS A JR
3/30
05:40 pm
ltrn
Form 8-K Lantern Pharma Inc. For: Mar 30
High
Report
Form 8-K Lantern Pharma Inc. For: Mar 30
3/30
05:40 pm
ltrn
Form 10-K Lantern Pharma Inc. For: Dec 31
High
Report
Form 10-K Lantern Pharma Inc. For: Dec 31
2/23
04:37 pm
ltrn
Form SCHEDULE 13D/A Lantern Pharma Inc. Filed by: Bios Equity Partners, LP
Low
Report
Form SCHEDULE 13D/A Lantern Pharma Inc. Filed by: Bios Equity Partners, LP
1/23
07:31 am
ltrn
Form 8-K Lantern Pharma Inc. For: Jan 22
Low
Report
Form 8-K Lantern Pharma Inc. For: Jan 22
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: